LACK OF EFFECT OF GENDER AND ORAL-CONTRACEPTIVE STEROIDS ON THE PHARMACOKINETICS OF (R)-IBUPROFEN IN HUMANS

被引:16
|
作者
KNIGHTS, KM
MCLEAN, CF
TONKIN, AL
MINERS, JO
机构
[1] FLINDERS UNIV S AUSTRALIA, DEPT ANAESTHESIA & INTENS CARE, BEDFORD PK, SA 5042, AUSTRALIA
[2] FLINDERS MED CTR, BEDFORD PK, SA 5042, AUSTRALIA
[3] UNIV ADELAIDE, DEPT CLIN & EXPTL PHARMACOL, ADELAIDE, SA 5000, AUSTRALIA
关键词
(R)-IBUPROFEN; GENDER; ORAL CONTRACEPTIVE STEROIDS; PHARMACOKINETICS; CHIRAL INVERSION;
D O I
10.1111/j.1365-2125.1995.tb05769.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of gender and oral contraceptive steroids on the pharmacokinetics of (R)-ibuprofen were studied in groups of healthy adult males, females and oral contraceptive steroid (OCS) using females. The values of AUG, CL(po), t(1/2) and V-ss,V-app did not differ significantly between the groups. Similarly, the percentage unbound of (R)-ibuprofen in pooled plasma from the three groups was not statistically different. Since chiral inversion is the major determinant of (R)-ibuprofen clearance in humans, it may be inferred from these data that gender and OCS have little or no effect on conversion of (R)-ibuprofen to the pharmacologically active S-enantiomer. Moreover, it is unlikely that hormonal factors influence the activity of the human hepatic long-chain fatty-acid:CoA ligase, the enzyme mediating the rate limiting step of (R)-ibuprofen inversion.
引用
收藏
页码:153 / 156
页数:4
相关论文
共 50 条
  • [1] THE LACK OF EFFECT OF SODIUM VALPROATE ON THE PHARMACOKINETICS OF ORAL-CONTRACEPTIVE STEROIDS
    CRAWFORD, P
    CHADWICK, D
    CLELAND, P
    TJIA, J
    COWIE, A
    BACK, DJ
    ORME, ML
    [J]. CONTRACEPTION, 1986, 33 (01) : 23 - 29
  • [2] EFFECT OF ORAL-CONTRACEPTIVE STEROIDS ON THE PHARMACOKINETICS OF PHENPROCOUMON
    MONIG, H
    BAESE, C
    HEIDEMANN, HT
    OHNHAUS, EE
    SCHULTE, HM
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (01) : 115 - 118
  • [3] CLINICAL PHARMACOKINETICS OF ORAL-CONTRACEPTIVE STEROIDS
    ORME, ML
    BACK, DJ
    BRECKENRIDGE, AM
    [J]. CLINICAL PHARMACOKINETICS, 1983, 8 (02) : 95 - 136
  • [4] LACK OF EFFECT OF ORAL-CONTRACEPTIVE USE ON THE PHARMACOKINETICS OF QUININE
    WANWIMOLRUK, S
    KAEWVICHIT, S
    TANTHAYAPHINANT, O
    SUWANNARACH, C
    ORANRATNACHAI, A
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (02) : 179 - 181
  • [5] THE LACK OF INTERACTION BETWEEN TEMAFLOXACIN AND COMBINED ORAL-CONTRACEPTIVE STEROIDS
    BACK, DJ
    TJIA, J
    MARTIN, C
    MILLAR, E
    MANT, T
    MORRISON, P
    ORME, M
    [J]. CONTRACEPTION, 1991, 43 (04) : 317 - 323
  • [8] PHARMACOKINETICS OF ORAL-CONTRACEPTIVE STEROIDS AFTER MORNING OR EVENING ADMINISTRATION
    KIRIWAT, O
    FOTHERBY, K
    [J]. CONTRACEPTION, 1983, 27 (02) : 153 - 160
  • [9] INHIBITION OF HEPATIC DEMETHYLATION OF AMINOPYRINE BY ORAL-CONTRACEPTIVE STEROIDS IN HUMANS
    HERZ, R
    KOELZ, HR
    HAEMMERLI, UP
    BENES, I
    BLUM, AL
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1978, 8 (01) : 27 - 30
  • [10] ORAL-CONTRACEPTIVE STEROIDS AND MALIGNANCY
    GRANT, E
    [J]. CLINICAL ONCOLOGY, 1982, 8 (02): : 97 - 102